OverviewSuggest Edit

Avitide is dedicated to advancing our partners clinical pipelines and commercial manufacturing processes with a rapid, exclusive, and enabling affinity purification platform technology. Avitide's industry-leading 3-month service and proprietary affinity resin discovery and development technology offers unparalleled speed, performance, and product resolution that will enable bioprocess programs to define a cost-effective affinity purification solution for any class of biopharmaceutical. A NEW STANDARD IN PRODUCT QUALITY, YIELD, AND PURITY. On-demand, molecule-specific affinity purification enables high yield and high purity purification processes for gene therapy vectors, vaccines, bispecific antibodies, and therapeutic proteins. Let's move beyond capture: Avitide delivers novel affinity resins that can select for product quality attributes to improve upon drug product purity, safety, and potency. BIOPROCESS-READY AFFINITY PURIFICATION PERFORMANCE. Avitide affinity resins are more cost-effective and scalable compared to other affinity ligand and resin manufacturing technologies. The proprietary peptide-based affinity ligands and scaffolds deliver high dynamic binding capacity and cleaning/sanitization stability. To ensure line of sight to commercial resin, affinity ligand manufacturability is assessed very early in the affinity resin discovery and development process (usually within 6 weeks) so that every affinity purification solution delivered is ready to meet the rigors of biopharmaceutical manufacturing.
HQLebanon, US

Latest Updates

Employees (est.) (Sept 2020)31(-3%)
Cybersecurity ratingBMore

Key People/Management at Avitide

Kevin Isett

Kevin Isett

Chief Executive Officer, CoFounder
Warren Kett

Warren Kett

Chief Scientific Officer, CoFounder
Tillman Gerngross

Tillman Gerngross

Chairman of the Board, Co Founder
Scott Kennedy

Scott Kennedy

Kimberly Cornwell

Kimberly Cornwell

General Counsel
Karol Lacki

Karol Lacki

VP Technology Development
Show more

Avitide Office Locations

Avitide has an office in Lebanon
Lebanon, US (HQ)
16 Cavendish Ct
Show all (1)

Avitide Financials and Metrics

Summary Metrics

Founding Date


Avitide total Funding

$11 m

Time since last funding

4 years ago

Avitide investors

Show all financial metrics

Avitide Cybersecurity Score

Cybersecurity ratingPremium dataset



SecurityScorecard logo

Avitide Online and Social Media Presence

Embed Graph

Avitide News and Updates

Biotech company Avitide attracts Series E funding

Lebanon, New Hampshire-based biotech company Avitide Inc has raised an undisclosed amount of Series E funding. Sands Capital Ventures LLC led the round with participation from Mithril Capital Management, Polaris Partners, NeoMed Management, OrbiMed Advisors and Borealis Ventures. In addition to the …

VC-backed Avitide hires one as CFO and another as tech development VP

Lebanon, New Hampshire-based biotech company Avitide Inc has named Scott Kennedy as chief financial officer and Karol Lacki as vice president of technology development. Previously, Kennedy was vice president and CFO of PerkinElmer's life sciences solutions division while Lacki worked at Novo Nordisk…

Avitide Frequently Asked Questions

  • When was Avitide founded?

    Avitide was founded in 2012.

  • Who are Avitide key executives?

    Avitide's key executives are Kevin Isett, Warren Kett and Tillman Gerngross.

  • How many employees does Avitide have?

    Avitide has 31 employees.

  • Who are Avitide competitors?

    Competitors of Avitide include Taysha Gene Therapies, Androvia LifeSciences and Biognosys.

  • Where is Avitide headquarters?

    Avitide headquarters is located at 16 Cavendish Ct, Lebanon.

  • Where are Avitide offices?

    Avitide has an office in Lebanon.

  • How many offices does Avitide have?

    Avitide has 1 office.